Responses
Clinical/translational cancer immunotherapy
Original research
Decrease in tumor content assessed in biopsies is associated with improved treatment outcome response to pembrolizumab in patients with rare tumors
Compose a Response to This Article
Other responses
No responses have been published for this article.